🕷️ Crawler Inspector

URL Lookup

Direct Parameter Lookup

Raw Queries and Responses

1. Shard Calculation

Query:

Response:

Calculated Shard: 90 (from laksa187)

2. Crawled Status Check

Query:

curl -X POST \
  'http://laksa090.int.ahrefs:8124/' \
  -H 'Content-Type: text/plain' \
  -H 'X-ClickHouse-Database: crawler3' \
  -H 'Authorization: Basic YXBpOg==' \
  -d 'SELECT getAhrefsURLFromUnparsed(src_unparsed) AS found_url, ifNull(toUnixTimestamp(download_stamp), 0) AS crawl_time, ifNull(toUnixTimestamp(props_url_first_seen), 0) AS first_indexed_time, download_http_code AS http_code, src_unparsed AS src_unparsed, src_root_hash AS src_root_hash, history_drop_reason AS history_drop_reason, meta_title AS meta_title, meta_descriptions AS meta_descriptions, attrs_boilerpipe_text AS attrs_boilerpipe_text, attrs_markdown AS attrs_markdown, attrs_readable_markdown AS attrs_readable_markdown, meta_canonical AS meta_canonical FROM crawler3.page_info_local FINAL PREWHERE (src_root_hash, src_unparsed) IN ((getAhrefsRootHashFromUnparsed(getAhrefsUnparsedNoserviceFromURL(\'https://www.emis.com/php/company-profile/MY/Pharmaniaga_Berhad_en_1662717.html\')), getAhrefsUnparsedNoserviceFromURL(\'https://www.emis.com/php/company-profile/MY/Pharmaniaga_Berhad_en_1662717.html\'))) FORMAT JSONEachRow'

Response:

{"found_url":"https:\/\/www.emis.com\/php\/company-profile\/MY\/Pharmaniaga_Berhad_en_1662717.html","crawl_time":1774566439,"first_indexed_time":1535409971,"http_code":200,"src_unparsed":"com,emis!www,\/php\/company-profile\/MY\/Pharmaniaga_Berhad_en_1662717.html s443","src_root_hash":"2762083924628895290","history_drop_reason":null,"meta_title":"Pharmaniaga Berhad Company Profile - Malaysia | Financials & Key Executives | EMIS","meta_descriptions":["Report with financial data, key executives contacts, ownership details & and more for Pharmaniaga Berhad in Malaysia. Report is available for immediate purchase & download from EMIS."],"attrs_boilerpipe_text":"Pharmaniaga Berhad is an enterprise in Malaysia, with the main office in Shah Alam. It operates in the Pharmaceutical and Medicine Manufacturing industry. Pharmaniaga Berhad was incorporated on March 26, 1998. It currently has a total number of 2,019 (2024) employees. There was a net sales revenue increase of 4.48% reported in Pharmaniaga Berhad’s latest financial highlights for 2025. Its’ total assets recorded a growth of 12.78%. The net profit margin of Pharmaniaga Berhad decreased by 2.27% in 2025.\nBasic Information\nTotal Employees:\nPurchase the Pharmaniaga Berhad report  to view the information.\nOutstanding Shares:\nPurchase the Pharmaniaga Berhad report  to view the information.\nFinancial Auditors:\nPurchase the Pharmaniaga Berhad report  to view the information.\nIncorporation Date:\nMarch 26, 1998\nKey Executives\nPurchase this report to view the information.\nChief Financial Officer\nPurchase this report to view the information.\nChief Operating Officer\nPurchase this report to view the information.\nManaging Director\nPurchase this report to view the information.\nDirector\/Member of the Board\nPurchase this report to view the information.\nDirector\/Member of the Board\nOwnership Details\nSubsidiaries\nCompany Performance\nCreated with Highstock 1.3.7\nChart context menu\nFinancial values in the chart are available after  Pharmaniaga Berhad report is purchased.\nLooking for more than just a company report?\nEMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.\nRequest a demo of the EMIS service\nKey Financial Highlights\nAnnual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the  purchased report.\nNet sales revenue\n4.48%\n▲\nTotal Operating Revenue\n4.42%\n▲\nOperating Profit\n-48.3%\n▼\nEBITDA\n-45.23%\n▼\nNet Profit\/Loss for the Period\n-62.12%\n▼\nTotal Assets\n12.78%\n▲\nTotal Equity\nN\/A\nOperating Profit Margin\n-3.55%\n▼\nNet Profit Margin\n-2.27%\n▼\nReturn on Equity (ROE)\nN\/A\nDebt \/ Equity\nN\/A\nQuick Ratio\n152.99%\n▲\nCash Ratio\n-0.01%\n▼","attrs_markdown":"- [\\$0.00 (0)]()\n- [EMIS Store](https:\/\/www.emis.com\/php\/store\/)\n- [Client log in](https:\/\/www.emis.com\/php\/login\/redirect)\n\n[Menu]()\n\n[Close]()\n\n[REQUEST A DEMO](https:\/\/www.emis.com\/php\/company-profile\/index\/trial)\n\n- [Back]()\n- [About EMIS](https:\/\/www.isimarkets.com\/emis\/ \"About EMIS\")\n- [Solutions](https:\/\/www.isimarkets.com\/#solutions \"Solutions\")\n- [News & Insights](https:\/\/www.isimarkets.com\/news\/ \"News & Insights\")\n- [ISI Markets](https:\/\/www.isimarkets.com\/ \"ISI Markets\")\n- [Data Delivery](https:\/\/www.isimarkets.com\/data-delivery\/ \"Data Delivery\")\n- [Customer Success](https:\/\/www.isimarkets.com\/customer-success\/ \"Customer Success\")\n- [\\$0.00 (0)](https:\/\/www.emis.com\/php\/store\/index\/basket)  [EMIS Store](https:\/\/www.emis.com\/php\/store\/)\n  [SELECT LANGUAGE]()\n  [Polski](https:\/\/www.emis.com\/pl) [Español](https:\/\/www.emis.com\/la) [Português](https:\/\/www.emis.com\/pt-br) [简体中文](https:\/\/www.emis.com\/zh-hant)\n  [Client log in](https:\/\/www.emis.com\/php\/login\/redirect)\n\nTotal\n\nUSD \\$0\\.00\n\n[View basket](https:\/\/www.emis.com\/php\/store\/index\/basket) [Checkout now]()\n\n[Home](https:\/\/www.emis.com\/php\/store)  [Malaysia](https:\/\/www.emis.com\/php\/company-profile\/MY\/main.html)  [Chemical Manufacturing](https:\/\/www.emis.com\/php\/company-profile\/MY\/Chemical_Manufacturing\/page1.html)  Pharmaniaga Berhad\n\n[Search more companies](https:\/\/www.emis.com\/php\/company-profile\/index\/screening)\n\n# Pharmaniaga Berhad (Malaysia)\nMain Activities: Pharmaceutical and Medicine Manufacturing \\| Pharmacies and Drug Stores \\| Management of Companies and Enterprises\n\nFull name: Pharmaniaga Berhad Profile Updated: January 15, 2026\n\nBuy our report for this company  [USD 29.95]()  Most recent financial data: 2025 Available in: English [Download a sample report](https:\/\/static-emis.emis.com\/emiscom\/files\/EMIS_example_full_report.pdf)\n\nPharmaniaga Berhad is an enterprise in Malaysia, with the main office in Shah Alam. It operates in the Pharmaceutical and Medicine Manufacturing industry. Pharmaniaga Berhad was incorporated on March 26, 1998. It currently has a total number of 2,019 (2024) employees. There was a net sales revenue increase of 4.48% reported in Pharmaniaga Berhad’s latest financial highlights for 2025. Its’ total assets recorded a growth of 12.78%. The net profit margin of Pharmaniaga Berhad decreased by 2.27% in 2025.\n\nHeadquarters  \n No. 7, Lorong Keluli 1B, Kawasan Perindustrian, Bukit Raja Selatan, Seksyen 7   \n Shah Alam; Selangor; Postal Code: 40000\n\nContact Details: Purchase the Pharmaniaga Berhad report to view the information.\n\nWebsite: <http:\/\/www.pharmaniaga.com>\n\nBasic Information\n\nTotal Employees:\n\nPurchase the Pharmaniaga Berhad report to view the information.\n\nOutstanding Shares:\n\nPurchase the Pharmaniaga Berhad report to view the information.\n\nFinancial Auditors:\n\nPurchase the Pharmaniaga Berhad report to view the information.\n\nIncorporation Date:\n\nMarch 26, 1998\n\nKey Executives\n\nPurchase this report to view the information.\n\nChief Financial Officer\n\nPurchase this report to view the information.\n\nChief Operating Officer\n\nPurchase this report to view the information.\n\nManaging Director\n\nPurchase this report to view the information.\n\nDirector\/Member of the Board\n\nPurchase this report to view the information.\n\nDirector\/Member of the Board\n\nOwnership Details\n\nPurchase this report to view the information.\n\n47\\.123%\n\nPurchase this report to view the information.\n\n7\\.835%\n\nSubsidiaries\n\nBio-Collagen Technologies Sdn. Bhd.\n\n100%\n\nEsteem Interpoint Sdn Bhd\n\n100%\n\nIdaman Pharma Manufacturing Sdn. Bhd.\n\n100%\n\nCompany Performance\n\nCreated with Highstock 1.3.7\n\nFinancial values in the chart are available after Pharmaniaga Berhad report is purchased.\n\nLooking for more than just a company report?\n\nEMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.\n\n[Request a demo of the EMIS service](https:\/\/www.emis.com\/php\/company-profile\/index\/trial)\n\nKey Financial Highlights\n\nAnnual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.\n\nNet sales revenue\n\n4\\.48%▲\n\nTotal Operating Revenue\n\n4\\.42%▲\n\nOperating Profit\n\n\\-48.3%▼\n\nEBITDA\n\n\\-45.23%▼\n\nNet Profit\/Loss for the Period\n\n\\-62.12%▼\n\nTotal Assets\n\n12\\.78%▲\n\nTotal Equity\n\nN\/A\n\nOperating Profit Margin\n\n\\-3.55%▼\n\nNet Profit Margin\n\n\\-2.27%▼\n\nReturn on Equity (ROE)\n\nN\/A\n\nDebt \/ Equity\n\nN\/A\n\nQuick Ratio\n\n152\\.99%▲\n\nCash Ratio\n\n\\-0.01%▼\n\n## Similar companies\n[Vance Bioenergy Sdn. Bhd.](https:\/\/www.emis.com\/php\/company-profile\/MY\/Vance_Bioenergy_Sdn_Bhd_en_3229836.html)\n\n[Igb Berhad](https:\/\/www.emis.com\/php\/company-profile\/MY\/Igb_Berhad_en_1661321.html)\n\n[Caring Pharmacy Group Berhad](https:\/\/www.emis.com\/php\/company-profile\/MY\/Caring_Pharmacy_Group_Berhad_en_3913234.html)\n\n[Apex Healthcare Bhd](https:\/\/www.emis.com\/php\/company-profile\/MY\/Apex_Healthcare_Bhd_en_1660200.html)\n\n[Duopharma Biotech Berhad](https:\/\/www.emis.com\/php\/company-profile\/MY\/Duopharma_Biotech_Berhad_en_1660913.html)\n\n[Pfizer (Malaysia) Sdn. Bhd.](https:\/\/www.emis.com\/php\/company-profile\/MY\/Pfizer__Malaysia__Sdn_Bhd_en_4260825.html)\n\n[Haleon Malaysia Sdn. Bhd.](https:\/\/www.emis.com\/php\/company-profile\/MY\/Haleon_Malaysia_Sdn_Bhd_en_2084514.html)\n\n[Sterling Drug (Malaya) S\/B](https:\/\/www.emis.com\/php\/company-profile\/MY\/Sterling_Drug__Malaya__SB_en_4205229.html)\n\n[Danone Specialized Nutrition (Malaysia) Sdn. Bhd.](https:\/\/www.emis.com\/php\/company-profile\/MY\/Danone_Specialized_Nutrition__Malaysia__Sdn_Bhd_en_4260790.html)\n\n[Nexsol (Malaysia) Sdn. Bhd.](https:\/\/www.emis.com\/php\/company-profile\/MY\/Nexsol__Malaysia__Sdn_Bhd_en_6700791.html)\n\n## Related EMIS Industry Reports\n![](https:\/\/emis-aws-static.emis.com\/common\/store\/reports\/industry\/937437215_000_w119.jpg)\n\n[Malaysia Pharma and Healthcare Sector Report 2026-2027](https:\/\/www.emis.com\/php\/store\/reports\/MY\/Malaysia_Pharma_and_Healthcare_Sector_Report_2026-2027_en_937437215.html \"Malaysia Pharma and Healthcare Sector Report 2026-2027\")\n\nAn EMIS Industry Report\n\n[Read more](https:\/\/www.emis.com\/php\/store\/reports\/MY\/Malaysia_Pharma_and_Healthcare_Sector_Report_2026-2027_en_937437215.html \"Malaysia Pharma and Healthcare Sector Report 2026-2027\")\n\n![](https:\/\/emis-aws-static.emis.com\/common\/store\/reports\/industry\/893744357_000_w119.jpg)\n\n[ASEAN Pharma and Healthcare Sector Report 2025-2026](https:\/\/www.emis.com\/php\/store\/reports\/MY\/ASEAN_Pharma_and_Healthcare_Sector_Report_2025-2026_en_893744357.html \"ASEAN Pharma and Healthcare Sector Report 2025-2026\")\n\nAn EMIS Industry Report\n\n[Read more](https:\/\/www.emis.com\/php\/store\/reports\/MY\/ASEAN_Pharma_and_Healthcare_Sector_Report_2025-2026_en_893744357.html \"ASEAN Pharma and Healthcare Sector Report 2025-2026\")\n\n![](https:\/\/emis-aws-static.emis.com\/common\/store\/reports\/industry\/879310097_000_w119.jpg)\n\n[Malaysia Pharma and Healthcare Sector Report 2025-2026](https:\/\/www.emis.com\/php\/store\/reports\/MY\/Malaysia_Pharma_and_Healthcare_Sector_Report_2025-2026_en_879310097.html \"Malaysia Pharma and Healthcare Sector Report 2025-2026\")\n\nAn EMIS Industry Report\n\n[Read more](https:\/\/www.emis.com\/php\/store\/reports\/MY\/Malaysia_Pharma_and_Healthcare_Sector_Report_2025-2026_en_879310097.html \"Malaysia Pharma and Healthcare Sector Report 2025-2026\")\n\n![](https:\/\/emis-aws-static.emis.com\/common\/store\/reports\/industry\/820056764_000_w119.jpg)\n\n[ASEAN Pharma and Healthcare Sector Report 2024-2025](https:\/\/www.emis.com\/php\/store\/reports\/MY\/ASEAN_Pharma_and_Healthcare_Sector_Report_2024-2025_en_820056764.html \"ASEAN Pharma and Healthcare Sector Report 2024-2025\")\n\nAn EMIS Industry Report\n\n[Read more](https:\/\/www.emis.com\/php\/store\/reports\/MY\/ASEAN_Pharma_and_Healthcare_Sector_Report_2024-2025_en_820056764.html \"ASEAN Pharma and Healthcare Sector Report 2024-2025\")\n\nTo view more information, [Request a demonstration of the EMIS service](https:\/\/www.emis.com\/php\/company-profile\/index\/trial)\n\n[USD 29.95]()\n\nBuy this company report\n\nNeed ongoing access to company, industry or country information?\n\n[Request a demo](https:\/\/www.emis.com\/php\/company-profile\/index\/trial)\n\n[About EMIS](https:\/\/www.isimarkets.com\/emis\/ \"About EMIS\") [About ISI Markets](https:\/\/www.isimarkets.com\/about\/ \"About ISI Markets\") [General Enquiries](https:\/\/www.isimarkets.com\/contact\/ \"General Enquiries\") [Request demo](https:\/\/www.emis.com\/php\/company-profile\/index\/trial \"Request demo\")\n\n[Events & Webinars](https:\/\/www.isimarkets.com\/events\/ \"Events & Webinars\") [Newsletter](https:\/\/www.isimarkets.com\/newsletter\/ \"Newsletter\") [Press Enquiries](https:\/\/www.isimarkets.com\/company\/press-enquiries\/ \"Store\") [Store](https:\/\/www.emis.com\/php\/store \"Store\")\n\n[Terms and Conditions](https:\/\/www.isimarkets.com\/terms\/ \"Terms and Conditions\") [Privacy Policy](https:\/\/www.isimarkets.com\/privacy\/ \"Privacy Policy\") [Cookie Policy](https:\/\/www.isimarkets.com\/cookies\/ \"Cookie Policy\")\n\nCopyright ©2026 ISI Markets. All rights reserved.\n\n![](https:\/\/www.facebook.com\/tr?id=1668886863352040&ev=PageView&noscript=1)","attrs_readable_markdown":"Pharmaniaga Berhad is an enterprise in Malaysia, with the main office in Shah Alam. It operates in the Pharmaceutical and Medicine Manufacturing industry. Pharmaniaga Berhad was incorporated on March 26, 1998. It currently has a total number of 2,019 (2024) employees. There was a net sales revenue increase of 4.48% reported in Pharmaniaga Berhad’s latest financial highlights for 2025. Its’ total assets recorded a growth of 12.78%. The net profit margin of Pharmaniaga Berhad decreased by 2.27% in 2025.\n\nBasic Information\n\nTotal Employees:\n\nPurchase the Pharmaniaga Berhad report to view the information.\n\nOutstanding Shares:\n\nPurchase the Pharmaniaga Berhad report to view the information.\n\nFinancial Auditors:\n\nPurchase the Pharmaniaga Berhad report to view the information.\n\nIncorporation Date:\n\nMarch 26, 1998\n\nKey Executives\n\nPurchase this report to view the information.\n\nChief Financial Officer\n\nPurchase this report to view the information.\n\nChief Operating Officer\n\nPurchase this report to view the information.\n\nManaging Director\n\nPurchase this report to view the information.\n\nDirector\/Member of the Board\n\nPurchase this report to view the information.\n\nDirector\/Member of the Board\n\nOwnership Details\n\nSubsidiaries\n\nCompany Performance\n\nCreated with Highstock 1.3.7\n\nFinancial values in the chart are available after Pharmaniaga Berhad report is purchased.\n\nLooking for more than just a company report?\n\nEMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.\n\n[Request a demo of the EMIS service](https:\/\/www.emis.com\/php\/company-profile\/index\/trial)\n\nKey Financial Highlights\n\nAnnual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.\n\nNet sales revenue\n\n4\\.48%▲\n\nTotal Operating Revenue\n\n4\\.42%▲\n\nOperating Profit\n\n\\-48.3%▼\n\nEBITDA\n\n\\-45.23%▼\n\nNet Profit\/Loss for the Period\n\n\\-62.12%▼\n\nTotal Assets\n\n12\\.78%▲\n\nTotal Equity\n\nN\/A\n\nOperating Profit Margin\n\n\\-3.55%▼\n\nNet Profit Margin\n\n\\-2.27%▼\n\nReturn on Equity (ROE)\n\nN\/A\n\nDebt \/ Equity\n\nN\/A\n\nQuick Ratio\n\n152\\.99%▲\n\nCash Ratio\n\n\\-0.01%▼","meta_canonical":null}

3. Robots.txt Check

Query:

Response:

4. Spam/Ban Check

Query:

Response:

5. Seen Status Check

ℹ️ Skipped - page is already crawled

📄

INDEXABLE

✅

CRAWLED

20 days ago

🤖

ROBOTS ALLOWED

Page Info Filters

Filter	Status	Condition	Details
HTTP status	PASS	`download_http_code = 200`	HTTP 200
Age cutoff	PASS	`download_stamp > now() - 6 MONTH`	0.7 months ago
History drop	PASS	`isNull(history_drop_reason)`	No drop reason
Spam/ban	PASS	`fh_dont_index != 1 AND ml_spam_score = 0`	ml_spam_score=0
Canonical	PASS	`meta_canonical IS NULL OR = '' OR = src_unparsed`	Not set

Page Details

Property	Value
URL	https://www.emis.com/php/company-profile/MY/Pharmaniaga_Berhad_en_1662717.html
Last Crawled	2026-03-26 23:07:19 (20 days ago)
First Indexed	2018-08-27 22:46:11 (7 years ago)
HTTP Status Code	200
Meta Title	Pharmaniaga Berhad Company Profile - Malaysia \| Financials & Key Executives \| EMIS
Meta Description	Report with financial data, key executives contacts, ownership details & and more for Pharmaniaga Berhad in Malaysia. Report is available for immediate purchase & download from EMIS.
Meta Canonical	null
Boilerpipe Text	Pharmaniaga Berhad is an enterprise in Malaysia, with the main office in Shah Alam. It operates in the Pharmaceutical and Medicine Manufacturing industry. Pharmaniaga Berhad was incorporated on March 26, 1998. It currently has a total number of 2,019 (2024) employees. There was a net sales revenue increase of 4.48% reported in Pharmaniaga Berhad’s latest financial highlights for 2025. Its’ total assets recorded a growth of 12.78%. The net profit margin of Pharmaniaga Berhad decreased by 2.27% in 2025. Basic Information Total Employees: Purchase the Pharmaniaga Berhad report to view the information. Outstanding Shares: Purchase the Pharmaniaga Berhad report to view the information. Financial Auditors: Purchase the Pharmaniaga Berhad report to view the information. Incorporation Date: March 26, 1998 Key Executives Purchase this report to view the information. Chief Financial Officer Purchase this report to view the information. Chief Operating Officer Purchase this report to view the information. Managing Director Purchase this report to view the information. Director/Member of the Board Purchase this report to view the information. Director/Member of the Board Ownership Details Subsidiaries Company Performance Created with Highstock 1.3.7 Chart context menu Financial values in the chart are available after Pharmaniaga Berhad report is purchased. Looking for more than just a company report? EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets. Request a demo of the EMIS service Key Financial Highlights Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report. Net sales revenue 4.48% ▲ Total Operating Revenue 4.42% ▲ Operating Profit -48.3% ▼ EBITDA -45.23% ▼ Net Profit/Loss for the Period -62.12% ▼ Total Assets 12.78% ▲ Total Equity N/A Operating Profit Margin -3.55% ▼ Net Profit Margin -2.27% ▼ Return on Equity (ROE) N/A Debt / Equity N/A Quick Ratio 152.99% ▲ Cash Ratio -0.01% ▼
Markdown	- [\$0.00 (0)]() - [EMIS Store](https://www.emis.com/php/store/) - [Client log in](https://www.emis.com/php/login/redirect) [Menu]() [Close]() [REQUEST A DEMO](https://www.emis.com/php/company-profile/index/trial) - [Back]() - [About EMIS](https://www.isimarkets.com/emis/ "About EMIS") - [Solutions](https://www.isimarkets.com/#solutions "Solutions") - [News & Insights](https://www.isimarkets.com/news/ "News & Insights") - [ISI Markets](https://www.isimarkets.com/ "ISI Markets") - [Data Delivery](https://www.isimarkets.com/data-delivery/ "Data Delivery") - [Customer Success](https://www.isimarkets.com/customer-success/ "Customer Success") - [\$0.00 (0)](https://www.emis.com/php/store/index/basket) [EMIS Store](https://www.emis.com/php/store/) [SELECT LANGUAGE]() [Polski](https://www.emis.com/pl) [Español](https://www.emis.com/la) [Português](https://www.emis.com/pt-br) [简体中文](https://www.emis.com/zh-hant) [Client log in](https://www.emis.com/php/login/redirect) Total USD \$0\.00 [View basket](https://www.emis.com/php/store/index/basket) [Checkout now]() [Home](https://www.emis.com/php/store) [Malaysia](https://www.emis.com/php/company-profile/MY/main.html) [Chemical Manufacturing](https://www.emis.com/php/company-profile/MY/Chemical_Manufacturing/page1.html) Pharmaniaga Berhad [Search more companies](https://www.emis.com/php/company-profile/index/screening) # Pharmaniaga Berhad (Malaysia) Main Activities: Pharmaceutical and Medicine Manufacturing \\| Pharmacies and Drug Stores \\| Management of Companies and Enterprises Full name: Pharmaniaga Berhad Profile Updated: January 15, 2026 Buy our report for this company [USD 29.95]() Most recent financial data: 2025 Available in: English [Download a sample report](https://static-emis.emis.com/emiscom/files/EMIS_example_full_report.pdf) Pharmaniaga Berhad is an enterprise in Malaysia, with the main office in Shah Alam. It operates in the Pharmaceutical and Medicine Manufacturing industry. Pharmaniaga Berhad was incorporated on March 26, 1998. It currently has a total number of 2,019 (2024) employees. There was a net sales revenue increase of 4.48% reported in Pharmaniaga Berhad’s latest financial highlights for 2025. Its’ total assets recorded a growth of 12.78%. The net profit margin of Pharmaniaga Berhad decreased by 2.27% in 2025. Headquarters No. 7, Lorong Keluli 1B, Kawasan Perindustrian, Bukit Raja Selatan, Seksyen 7 Shah Alam; Selangor; Postal Code: 40000 Contact Details: Purchase the Pharmaniaga Berhad report to view the information. Website: <http://www.pharmaniaga.com> Basic Information Total Employees: Purchase the Pharmaniaga Berhad report to view the information. Outstanding Shares: Purchase the Pharmaniaga Berhad report to view the information. Financial Auditors: Purchase the Pharmaniaga Berhad report to view the information. Incorporation Date: March 26, 1998 Key Executives Purchase this report to view the information. Chief Financial Officer Purchase this report to view the information. Chief Operating Officer Purchase this report to view the information. Managing Director Purchase this report to view the information. Director/Member of the Board Purchase this report to view the information. Director/Member of the Board Ownership Details Purchase this report to view the information. 47\.123% Purchase this report to view the information. 7\.835% Subsidiaries Bio-Collagen Technologies Sdn. Bhd. 100% Esteem Interpoint Sdn Bhd 100% Idaman Pharma Manufacturing Sdn. Bhd. 100% Company Performance Created with Highstock 1.3.7 Financial values in the chart are available after Pharmaniaga Berhad report is purchased. Looking for more than just a company report? EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets. [Request a demo of the EMIS service](https://www.emis.com/php/company-profile/index/trial) Key Financial Highlights Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report. Net sales revenue 4\.48%▲ Total Operating Revenue 4\.42%▲ Operating Profit \-48.3%▼ EBITDA \-45.23%▼ Net Profit/Loss for the Period \-62.12%▼ Total Assets 12\.78%▲ Total Equity N/A Operating Profit Margin \-3.55%▼ Net Profit Margin \-2.27%▼ Return on Equity (ROE) N/A Debt / Equity N/A Quick Ratio 152\.99%▲ Cash Ratio \-0.01%▼ ## Similar companies [Vance Bioenergy Sdn. Bhd.](https://www.emis.com/php/company-profile/MY/Vance_Bioenergy_Sdn_Bhd_en_3229836.html) [Igb Berhad](https://www.emis.com/php/company-profile/MY/Igb_Berhad_en_1661321.html) [Caring Pharmacy Group Berhad](https://www.emis.com/php/company-profile/MY/Caring_Pharmacy_Group_Berhad_en_3913234.html) [Apex Healthcare Bhd](https://www.emis.com/php/company-profile/MY/Apex_Healthcare_Bhd_en_1660200.html) [Duopharma Biotech Berhad](https://www.emis.com/php/company-profile/MY/Duopharma_Biotech_Berhad_en_1660913.html) [Pfizer (Malaysia) Sdn. Bhd.](https://www.emis.com/php/company-profile/MY/Pfizer__Malaysia__Sdn_Bhd_en_4260825.html) [Haleon Malaysia Sdn. Bhd.](https://www.emis.com/php/company-profile/MY/Haleon_Malaysia_Sdn_Bhd_en_2084514.html) [Sterling Drug (Malaya) S/B](https://www.emis.com/php/company-profile/MY/Sterling_Drug__Malaya__SB_en_4205229.html) [Danone Specialized Nutrition (Malaysia) Sdn. Bhd.](https://www.emis.com/php/company-profile/MY/Danone_Specialized_Nutrition__Malaysia__Sdn_Bhd_en_4260790.html) [Nexsol (Malaysia) Sdn. Bhd.](https://www.emis.com/php/company-profile/MY/Nexsol__Malaysia__Sdn_Bhd_en_6700791.html) ## Related EMIS Industry Reports ![](https://emis-aws-static.emis.com/common/store/reports/industry/937437215_000_w119.jpg) [Malaysia Pharma and Healthcare Sector Report 2026-2027](https://www.emis.com/php/store/reports/MY/Malaysia_Pharma_and_Healthcare_Sector_Report_2026-2027_en_937437215.html "Malaysia Pharma and Healthcare Sector Report 2026-2027") An EMIS Industry Report [Read more](https://www.emis.com/php/store/reports/MY/Malaysia_Pharma_and_Healthcare_Sector_Report_2026-2027_en_937437215.html "Malaysia Pharma and Healthcare Sector Report 2026-2027") ![](https://emis-aws-static.emis.com/common/store/reports/industry/893744357_000_w119.jpg) [ASEAN Pharma and Healthcare Sector Report 2025-2026](https://www.emis.com/php/store/reports/MY/ASEAN_Pharma_and_Healthcare_Sector_Report_2025-2026_en_893744357.html "ASEAN Pharma and Healthcare Sector Report 2025-2026") An EMIS Industry Report [Read more](https://www.emis.com/php/store/reports/MY/ASEAN_Pharma_and_Healthcare_Sector_Report_2025-2026_en_893744357.html "ASEAN Pharma and Healthcare Sector Report 2025-2026") ![](https://emis-aws-static.emis.com/common/store/reports/industry/879310097_000_w119.jpg) [Malaysia Pharma and Healthcare Sector Report 2025-2026](https://www.emis.com/php/store/reports/MY/Malaysia_Pharma_and_Healthcare_Sector_Report_2025-2026_en_879310097.html "Malaysia Pharma and Healthcare Sector Report 2025-2026") An EMIS Industry Report [Read more](https://www.emis.com/php/store/reports/MY/Malaysia_Pharma_and_Healthcare_Sector_Report_2025-2026_en_879310097.html "Malaysia Pharma and Healthcare Sector Report 2025-2026") ![](https://emis-aws-static.emis.com/common/store/reports/industry/820056764_000_w119.jpg) [ASEAN Pharma and Healthcare Sector Report 2024-2025](https://www.emis.com/php/store/reports/MY/ASEAN_Pharma_and_Healthcare_Sector_Report_2024-2025_en_820056764.html "ASEAN Pharma and Healthcare Sector Report 2024-2025") An EMIS Industry Report [Read more](https://www.emis.com/php/store/reports/MY/ASEAN_Pharma_and_Healthcare_Sector_Report_2024-2025_en_820056764.html "ASEAN Pharma and Healthcare Sector Report 2024-2025") To view more information, [Request a demonstration of the EMIS service](https://www.emis.com/php/company-profile/index/trial) [USD 29.95]() Buy this company report Need ongoing access to company, industry or country information? [Request a demo](https://www.emis.com/php/company-profile/index/trial) [About EMIS](https://www.isimarkets.com/emis/ "About EMIS") [About ISI Markets](https://www.isimarkets.com/about/ "About ISI Markets") [General Enquiries](https://www.isimarkets.com/contact/ "General Enquiries") [Request demo](https://www.emis.com/php/company-profile/index/trial "Request demo") [Events & Webinars](https://www.isimarkets.com/events/ "Events & Webinars") [Newsletter](https://www.isimarkets.com/newsletter/ "Newsletter") [Press Enquiries](https://www.isimarkets.com/company/press-enquiries/ "Store") [Store](https://www.emis.com/php/store "Store") [Terms and Conditions](https://www.isimarkets.com/terms/ "Terms and Conditions") [Privacy Policy](https://www.isimarkets.com/privacy/ "Privacy Policy") [Cookie Policy](https://www.isimarkets.com/cookies/ "Cookie Policy") Copyright ©2026 ISI Markets. All rights reserved. ![](https://www.facebook.com/tr?id=1668886863352040&ev=PageView&noscript=1)
Readable Markdown	Pharmaniaga Berhad is an enterprise in Malaysia, with the main office in Shah Alam. It operates in the Pharmaceutical and Medicine Manufacturing industry. Pharmaniaga Berhad was incorporated on March 26, 1998. It currently has a total number of 2,019 (2024) employees. There was a net sales revenue increase of 4.48% reported in Pharmaniaga Berhad’s latest financial highlights for 2025. Its’ total assets recorded a growth of 12.78%. The net profit margin of Pharmaniaga Berhad decreased by 2.27% in 2025. Basic Information Total Employees: Purchase the Pharmaniaga Berhad report to view the information. Outstanding Shares: Purchase the Pharmaniaga Berhad report to view the information. Financial Auditors: Purchase the Pharmaniaga Berhad report to view the information. Incorporation Date: March 26, 1998 Key Executives Purchase this report to view the information. Chief Financial Officer Purchase this report to view the information. Chief Operating Officer Purchase this report to view the information. Managing Director Purchase this report to view the information. Director/Member of the Board Purchase this report to view the information. Director/Member of the Board Ownership Details Subsidiaries Company Performance Created with Highstock 1.3.7 Financial values in the chart are available after Pharmaniaga Berhad report is purchased. Looking for more than just a company report? EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets. [Request a demo of the EMIS service](https://www.emis.com/php/company-profile/index/trial) Key Financial Highlights Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report. Net sales revenue 4\.48%▲ Total Operating Revenue 4\.42%▲ Operating Profit \-48.3%▼ EBITDA \-45.23%▼ Net Profit/Loss for the Period \-62.12%▼ Total Assets 12\.78%▲ Total Equity N/A Operating Profit Margin \-3.55%▼ Net Profit Margin \-2.27%▼ Return on Equity (ROE) N/A Debt / Equity N/A Quick Ratio 152\.99%▲ Cash Ratio \-0.01%▼
Shard	90 (laksa)
Root Hash	2762083924628895290
Unparsed URL	com,emis!www,/php/company-profile/MY/Pharmaniaga_Berhad_en_1662717.html s443